West Pharmaceutical Services (WST) News Today $227.84 +4.07 (+1.82%) As of 11:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is West Pharmaceutical Services Up Today?West Pharmaceutical Services, Inc. (WST) shares have pulled back amid a spate of securities‐class‐action filings, even as Wall Street analysts maintain a bullish outlook on the stock. Analyst consensus price target of $332.50 implies roughly 27% upside, reflecting recent upgrades to earnings estimates. Numerous investor‐rights firms (Rosen, Levi & Korsinsky, Faruqi & Faruqi, Bronstein, Gewirtz & Grossman, Glancy Prongay & Murray, The Gross Law Firm, etc.) have issued reminders of the July 7, 2025 deadline to seek lead‐plaintiff status in existing class actions. At least eight separate securities‐fraud lawsuits allege violations of federal laws for the February 2023–February 2025 period, raising concerns about potential legal costs, settlements and reputational damage. Posted 6m agoAI Generated. May Contain Errors. WST Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical ServicesJune 10 at 10:11 AM | prnewswire.comWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by Terra Alpha Investments LLCTerra Alpha Investments LLC raised its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 29.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,057 shares of theJune 10 at 8:27 AM | marketbeat.comFirst National Bank Sioux Falls Acquires New Stake in West Pharmaceutical Services, Inc. (NYSE:WST)First National Bank Sioux Falls acquired a new stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 2,135 shares of the medical instruments supplier's stock, valued at approximately $478,June 10 at 6:33 AM | marketbeat.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WSTJune 10 at 5:45 AM | prnewswire.comPark Avenue Securities LLC Has $2.50 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)Park Avenue Securities LLC boosted its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 28.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,157 shares of the medical instruments supplierJune 10 at 4:38 AM | marketbeat.comShareholders that lost money on West Pharmaceutical Services, Inc. (WST) Urged to Join Class Action – Contact The Gross Law Firm to Learn MoreJune 9 at 1:32 PM | globenewswire.comDeadline Alert: West Pharmaceutical Services, Inc. ...June 9 at 12:20 PM | gurufocus.comDeadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitJune 9 at 12:00 PM | globenewswire.comWST Lawsuit Alert! Class Action Lawsuit Against West Pharmaceutical Services, Inc.June 9 at 7:31 AM | tipranks.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West ...June 9 at 6:05 AM | gurufocus.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WSTJune 9 at 5:45 AM | prnewswire.comWest Pharmaceutical Services, Inc. (NYSE:WST) Receives $332.50 Consensus Target Price from AnalystsJune 9 at 2:07 AM | americanbankingnews.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. ...June 8 at 8:19 AM | gurufocus.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WSTJune 8 at 7:26 AM | globenewswire.comSeilern Investment Management Ltd Decreases Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Seilern Investment Management Ltd lessened its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 0.6% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 441,357 shares of the medical instruments supplier's stock after selling 2,4June 8 at 6:39 AM | marketbeat.comPrinceton Global Asset Management LLC Has $222,000 Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)Princeton Global Asset Management LLC lessened its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 60.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 990 shares of the medical instrJune 8 at 5:33 AM | marketbeat.comGateway Investment Advisers LLC Buys New Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Gateway Investment Advisers LLC purchased a new position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 49,543 shares of the medical instrumJune 8 at 5:12 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WSTJune 7 at 10:00 AM | prnewswire.comBlue Zone Wealth Advisors LLC Acquires 10,571 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Blue Zone Wealth Advisors LLC grew its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 62.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 27,615 shares of the medical instruments supplier's stock after purchasingJune 7 at 7:31 AM | marketbeat.comCongress Asset Management Co. Sells 35,796 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Congress Asset Management Co. decreased its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 12.4% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 253,252 shares of the medical instruments supplier's stock aJune 7 at 6:48 AM | marketbeat.comWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by Hennion & Walsh Asset Management Inc.Hennion & Walsh Asset Management Inc. boosted its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 28.6% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,026 shares of the medical instruments supplJune 7 at 4:43 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WSTJune 6, 2025 | globenewswire.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical ServicesJune 6, 2025 | prnewswire.comWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Vest Financial LLCVest Financial LLC decreased its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 7.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 158,917 shares of the medical instruments supplier's stock after seJune 6, 2025 | marketbeat.comShareholders that lost money on West Pharmaceutical Services, Inc.(WST) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreJune 6, 2025 | prnewswire.comWest Pharmaceutical Services, Inc. (NYSE:WST) Receives Consensus Recommendation of "Buy" from AnalystsShares of West Pharmaceutical Services, Inc. (NYSE:WST - Get Free Report) have earned a consensus rating of "Buy" from the eight ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and oJune 6, 2025 | marketbeat.comWST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitJune 5, 2025 | globenewswire.comWST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud LawsuitJune 5, 2025 | prnewswire.comWest Pharmaceutical Services, Inc. (WST), Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJune 5, 2025 | prnewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WSTJune 5, 2025 | globenewswire.comLevi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 – WSTJune 5, 2025 | globenewswire.comAnnex Advisory Services LLC Has $13.40 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)Annex Advisory Services LLC raised its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 23.1% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 59,866 shares of the medical instruments supplier's stock after acquiring an additionalJune 5, 2025 | marketbeat.comContact The Gross Law Firm by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc.(WST)June 5, 2025 | prnewswire.comGAMMA Investing LLC Has $31.58 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)GAMMA Investing LLC raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 10,766.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 141,044 shares ofJune 5, 2025 | marketbeat.comWest Pharmaceutical Services, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – WSTJune 4, 2025 | globenewswire.comRhumbline Advisers Boosts Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Rhumbline Advisers increased its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 8.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 236,797 shares of the medical instrJune 4, 2025 | marketbeat.comSquarepoint Ops LLC Has $638,000 Position in West Pharmaceutical Services, Inc. (NYSE:WST)Squarepoint Ops LLC cut its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 97.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,947 shares of the medical instruments supplier's stoJune 4, 2025 | marketbeat.comWST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJune 3, 2025 | globenewswire.comWest Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJune 3, 2025 | prnewswire.comWest Pharmaceutical Services: Mixed Results And A Pricey Stock Makes This A PassJune 2, 2025 | seekingalpha.comSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical ServicesJune 2, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WSTJune 2, 2025 | globenewswire.comDeadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitJune 2, 2025 | globenewswire.comInvestors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025June 1, 2025 | markets.businessinsider.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West ...June 1, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WSTJune 1, 2025 | prnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. ...June 1, 2025 | gurufocus.comROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WSTJune 1, 2025 | globenewswire.comFirst Hawaiian Bank Cuts Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)First Hawaiian Bank decreased its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 32.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,092 shareJune 1, 2025 | marketbeat.comROSEN, NATIONAL INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WSTMay 31, 2025 | markets.businessinsider.com Get West Pharmaceutical Services News Delivered to You Automatically Sign up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter. Email Address WST Media Mentions By Week WST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WST News Sentiment▼0.280.68▲Average Medical News Sentiment WST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WST Articles This Week▼3414▲WST Articles Average Week Get West Pharmaceutical Services News Delivered to You Automatically Sign up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies COO News Today ALGN News Today MMSI News Today HAE News Today ICUI News Today XRAY News Today QDEL News Today NEOG News Today STAA News Today CERS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:WST) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding West Pharmaceutical Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share West Pharmaceutical Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
